Patient profiles
| Patient no., age/sex . | Diagnosis . | Duration* . | Leukocytes (109/L) . | Hemoglobin (g/dL) . | Therapy . | T cells % CD59− . | BM cells† % DAF−/CD59− . |
|---|---|---|---|---|---|---|---|
| 1, 24/M | PNH | 7 | 3.5 | 7.4 | Prednisolone | 17 | ND |
| 2, 31/M | PNH | 10 | 3.8 | 8.0 | Cyclosporine, G-CSF | 11 | 35 |
| 3, 52/F | PNH | 7 | 3.0 | 7.5 | None | 17 | ND |
| 4, 61/M | PNH | 7 | 3.5 | 11.7 | None | 6 | ND |
| 5, 63/M | PNH | 14 | 6.0 | 6.1 | Prednisolone Methenolone acetate | 5 | ND |
| 6, 66/F | PNH | 19 | 2.9 | 11.9 | Methenolone acetate | 36 | ND |
| 7, 75/F | PNH | 3 | 5.0 | 10.1 | Prednisolone | 6 | 53 |
| 8, 77/M | PNH | 6 | 4.9 | 13.3 | Prednisolone Methenolone acetate | 1 | ND |
| 9, 22/F | AA-PNH | 4 | 7.2 | 12.6 | Cyclosporine, G-CSF | 5 | 23 |
| 10, 59/M | AA-PNH | 5 | 3.5 | 14.0 | Methenolone acetate | 1 | ND |
| 11, 62/F | AA-PNH | 0.2 | 3.2 | 6.8 | Cyclosporine, G-CSF | 1 | 6 |
| 12, 68/F | AA-PNH | 7 | 3.9 | 9.8 | Prednisolone | 2 | 67 |
| Patient no., age/sex . | Diagnosis . | Duration* . | Leukocytes (109/L) . | Hemoglobin (g/dL) . | Therapy . | T cells % CD59− . | BM cells† % DAF−/CD59− . |
|---|---|---|---|---|---|---|---|
| 1, 24/M | PNH | 7 | 3.5 | 7.4 | Prednisolone | 17 | ND |
| 2, 31/M | PNH | 10 | 3.8 | 8.0 | Cyclosporine, G-CSF | 11 | 35 |
| 3, 52/F | PNH | 7 | 3.0 | 7.5 | None | 17 | ND |
| 4, 61/M | PNH | 7 | 3.5 | 11.7 | None | 6 | ND |
| 5, 63/M | PNH | 14 | 6.0 | 6.1 | Prednisolone Methenolone acetate | 5 | ND |
| 6, 66/F | PNH | 19 | 2.9 | 11.9 | Methenolone acetate | 36 | ND |
| 7, 75/F | PNH | 3 | 5.0 | 10.1 | Prednisolone | 6 | 53 |
| 8, 77/M | PNH | 6 | 4.9 | 13.3 | Prednisolone Methenolone acetate | 1 | ND |
| 9, 22/F | AA-PNH | 4 | 7.2 | 12.6 | Cyclosporine, G-CSF | 5 | 23 |
| 10, 59/M | AA-PNH | 5 | 3.5 | 14.0 | Methenolone acetate | 1 | ND |
| 11, 62/F | AA-PNH | 0.2 | 3.2 | 6.8 | Cyclosporine, G-CSF | 1 | 6 |
| 12, 68/F | AA-PNH | 7 | 3.9 | 9.8 | Prednisolone | 2 | 67 |